Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The Luye Life Sciences Group announced the opening of its new Boston R&D Center, the second global R&D facility set up in the United States.
read more
Lupin and Mylan announced they will partner to commercialize a biosimilar to Enbrel.
read more
Wednesday, December 26, 2018
Lupin Limited and AbbVie announced that AbbVie has licensed Lupin’s MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.
read more
Lupin and Rep. Bonnie Watson Coleman celebrated the grand opening of the company's 100,000 square foot expansion of its manufacturing facilities in Somerset.
read more
Lupin is voluntarily recalling Metformin Hydrochloride Extended-Release Tablets USP 500mg, lot G901203 to the consumer level.
read more
Wednesday, March 23, 2016
Lundbeck, a global pharmaceutical company, has chosen ArisGlobal® to complete the upgrade of its regulatory and safety systems on the agOnDemand™ platform.
read more
Lumosa Therapeutics Co., a Taipei-based biopharmaceutical company developing innovative therapies focused on the treatment of neurological and inflammatory disease, has announced that the FDA has confirmed the 505(b)(2) regulatory pathway is ...
read more
Lumos Diagnostics and RPS Diagnostics announced they have merged. The combined company will be called Lumos Diagnostics.
read more
Luminex announced the company submitted the ARIES® MRSA Assay to the U.S. Food and Drug Administration (FDA) for clearance.
read more
Luminer has streamlined its product inspection capabilities by introducing a dedicated 7,000-square-foot inspection suite at its primary manufacturing facility in Lakewood, NJ.
read more
Monday, November 25, 2019
Luminer has completed an expansion of its primary manufacturing facility in Lakewood, NJ.
read more
Luminer has incorporated a new state-of-the-art ECL production line at its primary manufacturing facility in Lakewood, NJ.
read more
Lumanity announced the acquisition of Endpoint Outcomes, a company specializing in harnessing the voice of patients to document the impact of treatments on health-related quality of life.
read more
Monday, November 05, 2018
The Lubrizol Corporation announces it will invest more than $25 million in its Calvert City, Kentucky manufacturing facility.
read more
Friday, November 14, 2014
The Lubrizol Corporation’s LifeSciences business, a
leading supplier of advanced materials for the pharmaceutical and medical device
industry, will showcase its extensive range of material solutions for the pharmaceutical
industry at the ...
read more